FilingSEC EDGAR8-K
Ernexa Therapeutics Appoints Robert J. Spiegel as Director
· SEC accepted
StageDirector Appointment
Filing content
Ernexa Therapeutics announced the appointment of Robert J. Spiegel, M.D. to its board of directors, effective September 14, 2026.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…